---
title: "VKTX.US (VKTX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/VKTX.US/news.md"
symbol: "VKTX.US"
name: "VKTX.US"
parent: "https://longbridge.com/en/quote/VKTX.US.md"
datetime: "2026-05-20T16:51:12.628Z"
locales:
  - [en](https://longbridge.com/en/quote/VKTX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/VKTX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/VKTX.US/news.md)
---

# VKTX.US (VKTX.US) — Related News

### [10 Health Care Stocks Whale Activity In Today's Session](https://longbridge.com/en/news/286138923.md)
*2026-05-12T17:35:39.000Z*
> Today's whale activity in health care stocks reveals significant trading opportunities. Notable options include bullish 

### [Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTURE-Oral Dosing Trial of VK2735 at European Congress on Obesity (ECO) 2026 | VKTX Stock News](https://longbridge.com/en/news/286085867.md)
*2026-05-12T03:05:33.000Z*
> Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTURE-Oral Dosing Trial of VK2735 at European Congress on O

### [Viking Therapeutics Announces Two Poster Presentations at European Congress on Obesity (ECO) 2026 | VKTX Stock News](https://longbridge.com/en/news/285192819.md)
*2026-05-05T03:05:32.000Z*
> Viking Therapeutics Announces Two Poster Presentations at European Congress on Obesity (ECO) 2026 | VKTX Stock News

### [Nash Maintains Buy on Viking Therapeutics, Keeps $107 Price Target Unchanged Amid Strong Cash Runway and Expanded VK2735 Study](https://longbridge.com/en/news/285077523.md)
*2026-05-04T13:05:41.000Z*
> Analyst Edward Nash from Canaccord Genuity has maintained a Buy rating on Viking Therapeutics with a price target of $10

### [Viking Therapeutics' (VKTX) "Buy" Rating Reaffirmed at BTIG Research](https://longbridge.com/en/news/285070869.md)
*2026-05-04T12:23:17.000Z*
> BTIG Research has reaffirmed a "buy" rating for Viking Therapeutics (VKTX) with a target price of $125.00, indicating a 

### [This weight loss stock may double or more in price over the next 12 months](https://longbridge.com/en/news/284907193.md)
*2026-05-01T13:57:45.000Z*
> In the biopharmaceutical field, analysts have a strong price expectation for Viking Therapeutics (VKTX) over the next 12